These include several prior validated targets affected in DCM patients with the RBM20 S635A mutation, such as TTN, CAMK2D, OBSCN, RYR2, IMMT, and TNNT2 (Fig. 4b–d, and Supplementary Fig. 5b)16. This evidence concerns the gene OBSCN and familial dilated cardiomyopathy.